HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence and characteristics of patients with pseudoakathisia.

Abstract
Pseudoakathisia (PsA) is characterised by the typical motor features of akathisia but there is a lack of subjective awareness. A total of 153 in-patients on neuroleptic medication hospitalized in two representative wards of the Psychiatric Hospital of Attica in Athens were rated on the census date using the Rating Scale for Drug-Induced Akathisia [Barnes, Br. J. Psychiatry, 154 (1989) 672-676], the Rating Scale for Extrapyramidal Side-Effects [Simpson and Angus, Acta Psychiatr. Scand. 212 (Suppl.) (1970) 11-19] and the Abnormal Involuntary Movements Scale [US Department of Health, Education and Welfare, ECDEU Assessment Manual (1976) pp. 534-537]. Eight subjects of the total in-patient population were found to have PsA of chronic type (point prevalence 5.23%). The point-prevalence of PsA among schizophrenic patients was 4.76%. In addition to the diagnosis of chronic pseudoakathisia, five patients (62.5%) had a concurrent diagnosis of chronic parkinsonism. Among patients with PsA, significant correlations were found between parkinsonism score and current daily dose of neuroleptics or high potency neuroleptics. There is evidence of a relationship between chronic pseudoakathisia, chronic parkinsonism and daily dose of neuroleptic.
AuthorsB J Havaki-Kontaxaki, V P Kontaxakis, G N Christodoulou
JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (Eur Neuropsychopharmacol) Vol. 10 Issue 5 Pg. 333-6 (Sep 2000) ISSN: 0924-977X [Print] Netherlands
PMID10974603 (Publication Type: Journal Article)
Chemical References
  • Antiparkinson Agents
  • Antipsychotic Agents
  • Haloperidol
  • Chlorpromazine
Topics
  • Adult
  • Akathisia, Drug-Induced (complications, epidemiology, physiopathology)
  • Antiparkinson Agents (adverse effects)
  • Antipsychotic Agents (adverse effects)
  • Chlorpromazine (adverse effects)
  • Chronic Disease
  • Female
  • Greece (epidemiology)
  • Haloperidol (adverse effects)
  • Hospitals, Psychiatric
  • Humans
  • Inpatients
  • Male
  • Middle Aged
  • Parkinson Disease (complications)
  • Prevalence
  • Schizophrenia (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: